# Finasteride for Chronic Central Serous Chorioretinopathy

> **NCT01585441** · PHASE2 · TERMINATED · sponsor: **National Eye Institute (NEI)** · enrollment: 6 (actual)

## Conditions studied

- Retinal Disease

## Interventions

- **DRUG:** Finasteride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01585441
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-04
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** This study was terminated early due to lack of enrollment.
- **Last updated:** 2014-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01585441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01585441, "Finasteride for Chronic Central Serous Chorioretinopathy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01585441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*